NEPHROPLUS — Nephrocare Health Services Income Statement
0.000.00%
Last trade - 00:00- IN₹60.96bn
- IN₹60.96bn
- IN₹7.56bn
Annual income statement for Nephrocare Health Services, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 4,373 | 5,662 | 7,558 | 9,988 |
| Cost of Revenue | ||||
| Gross Profit | 2,836 | 3,855 | 5,459 | 7,721 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 4,356 | 5,185 | 6,606 | 8,625 |
| Operating Profit | 17.2 | 477 | 952 | 1,363 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -85.9 | 332 | 874 | 975 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -118 | 351 | 671 | 768 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -118 | 351 | 671 | 768 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -118 | 351 | 671 | 768 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -1.17 | 3.59 | 6.72 | 8.1 |